Company intelligence / Profile preview

PainTEQ

Tampa, Florida, United Statespainteq.com ↗

Ownership: Private
Employees: ~40
Development stage: Other

Overview

PainTEQ has developed and commercialized the LinQ SI Joint Stabilization System, a minimally invasive device-based procedure for sacroiliac joint dysfunction. The company has completed significant clinical enrollment for its SECURE study and continues to expand its intellectual property portfolio with multiple patents granted for both implant design and surgical instrumentation. Clinical results indicate high patient satisfaction and improved outcomes compared to traditional surgery.

Therapeutic areas: Rheumatology
Modalities: DeviceAllograft implant
Industry: Implantable Medical Devices

Partnerships

Evolve Restorative Center (clinical research partner)Celeri Health (clinical research partner)

Beyond the preview

Go deeper on PainTEQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PainTEQ.

Explore the full profile